Antibiotic Resistance – Causes, Risks and Prevention

What Is Antibiotic Resistance?

Antibiotic resistance occurs when bacteria evolve mechanisms that allow them to survive and multiply despite the presence of antibiotics that were once effective against them. Infections caused by resistant bacteria are harder to treat, last longer, and can become life-threatening. The World Health Organization (WHO) has identified antibiotic resistance as one of the biggest threats to global health, food security, and development.

Causes of Antibiotic Resistance

While resistance can develop naturally through bacterial evolution, human activity has dramatically accelerated this process. Key contributing factors include:

• Overuse in human medicine: Antibiotics are frequently prescribed for viral infections such as the common cold or influenza, against which they have no effect.
• Use in agriculture and livestock: Antibiotics are widely used in farming to promote animal growth and prevent disease, contributing to the spread of resistant bacteria in the environment.
• Incomplete treatment courses: When patients stop taking antibiotics before the full course is completed, surviving bacteria may develop resistance.
• Poor infection control: Inadequate hand hygiene and infection control practices in hospitals and communities facilitate the spread of resistant strains.
• Global travel and trade: Resistant bacteria can spread rapidly across borders through international travel and the global food supply chain.

Biological Mechanisms of Resistance

Bacteria employ several molecular strategies to defend against antibiotics:

• Enzymatic inactivation: Bacteria produce enzymes such as beta-lactamases that chemically destroy antibiotic molecules before they can act.
• Target modification: Bacteria alter the molecular targets that antibiotics bind to, rendering the drug ineffective.
• Efflux pumps: Bacteria actively pump antibiotic molecules out of their cells before they can cause damage.
• Reduced permeability: Changes in the bacterial cell wall prevent antibiotics from entering the cell.
• Horizontal gene transfer: Resistance genes can be transferred between different bacterial strains and even between species, accelerating the spread of resistance.

Clinical Relevance and Symptoms

Antibiotic resistance is not a symptom itself but a microbiological phenomenon with serious clinical consequences. It becomes apparent when a bacterial infection fails to respond to standard antibiotic treatment. Warning signs may include:

• No improvement after several days of antibiotic therapy
• Recurring infections despite treatment
• Severe infections requiring hospitalization

Particularly dangerous are multidrug-resistant organisms (MDROs), which are resistant to multiple classes of antibiotics simultaneously. Well-known examples include MRSA (Methicillin-resistant Staphylococcus aureus), VRE (Vancomycin-resistant Enterococci), and ESBL-producing Enterobacteriaceae.

Diagnosis

Antibiotic resistance is identified through laboratory microbiological testing:

• Culture and isolation: The causative organism is grown from a patient sample such as blood, urine, or wound swab.
• Antibiogram (susceptibility testing): The isolated bacteria are tested against a panel of antibiotics to determine which ones are effective (sensitive), partially effective (intermediate), or ineffective (resistant).
• Molecular diagnostics: PCR-based methods can directly detect specific resistance genes in patient samples, allowing for rapid identification.

Treatment Options

Treating infections caused by resistant bacteria is a significant medical challenge. Available approaches include:

• Last-resort antibiotics: Drugs such as colistin or linezolid are reserved for infections caused by multidrug-resistant organisms and used only when other options have failed.
• Combination therapy: Using two or more antibiotics together can sometimes overcome resistance mechanisms.
• Targeted therapy based on antibiogram results: Selecting the most appropriate antibiotic based on susceptibility testing improves treatment outcomes and reduces unnecessary broad-spectrum use.
• Novel treatment strategies: Research into new antibiotics, bacteriophage therapy, and other antimicrobial approaches is being intensified to address the growing resistance crisis.

Prevention

Combating antibiotic resistance requires coordinated action at the individual, healthcare, and policy levels:

• Use antibiotics only when prescribed by a healthcare professional and complete the full course
• Never self-medicate with antibiotics
• Practice good hand hygiene and follow infection control measures in healthcare settings
• Use vaccinations to prevent bacterial infections and reduce the need for antibiotics
• Support policies that regulate antibiotic use in agriculture
• Promote public awareness about the responsible use of antibiotics

References

1. World Health Organization (WHO): Antimicrobial Resistance. Global Action Plan on Antimicrobial Resistance. WHO, Geneva, 2015. Available at: https://www.who.int/publications/i/item/9789241509763
2. Centers for Disease Control and Prevention (CDC): Antibiotic Resistance Threats in the United States. Atlanta, 2019. Available at: https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html
3. Laxminarayan R. et al.: Antibiotic resistance -- the need for global solutions. The Lancet, 2013; 382(9889): 1057-1098.